|
|
Other links at Articles > HIV/AIDS |
| 1. |
FDA Safety Changes: Aygestin, Viracept, Dipentum
|
|
|
The FDA has approved revisions to the safety labeling for norethindrone acetate tablets (Aygestin), nelfinavir mesylate tablets and oral powder (Viracept), and olsalazine sodium capsules (Dipentum). Medscape Medical News
|
| 3. |
Liposomal Doxorubicin Plus IL-12 Effective in AIDS-Related Kaposi Sarcoma
|
|
|
Thirty of 36 patients with advanced AIDS-related Kaposi sarcoma treated with cyclical pegylated liposomal doxorubicin plus interleukin-12 (IL-12) had a major response to treatment, according to investigators at the National Cancer Institute in Bethesda, Maryland. Reuters Health Information
|
|
|